Potential link between Helicobacter pylori and ischemic heart disease: Does the bacterium elicit thrombosis?

Minerva Medica

Volumn 101, Issue 2, 2010, Pages 121-125

  Fagoonee, S ^a   De Angelis, C ^b   Elia, C ^b   Silvano, S ^b   Oliaro, E ^b   Rizzetto, M ^b   Pellicano, R ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

Author keywords

Helicobacter pylori; Ischemia; Myocardial infarction; Thrombosis

Indexed keywords

GLYCOPROTEIN IB; VON WILLEBRAND FACTOR;

DISEASE ASSOCIATION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; ISCHEMIC HEART DISEASE; NONHUMAN; REVIEW; THROMBOCYTE AGGREGATION; THROMBOSIS;

CORONARY ARTERY DISEASE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PLATELET AGGREGATION; RISK FACTORS; THROMBOSIS;

EID: 77954744673     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Bainton D, Jones GR, Hole D. Influenza and ischaemic heart disease - a possible trigger for acute myocardial infarction? Int J Epidemiol 1978;7:231-9.
2. Mattila KJ, Nieminen MS, Valtonen W, Rasi VP, Kesaniemi YA, Syrjala SL et al. Association between dental health and acute myocardial infarction. BMJ 1989;298:779-81.
3. Guiglia R, Lo Russo L, Coccia E, Di Liberto C, D'Angelo M, Indovina G et al. The association between periodontal diseases and cardiovascular diseases: a narrative review. Panminerva Med 2008;50:327-37.
4. Dore MP, Graham DY. Gastritis, dyspepsia and peptic ulcer disease. Minerva Med 2008;99:323-33.
5. Berrutti M, Pellicano R, Fagoonee S, Astegiano M, Smedile A, Saracco G et al. Potential relationship between Helicobacter pylori and ischemic heart disease:any pathogenic model? Panminerva Med 2008;50:161-3.
6. Pellicano R, Ménard A, Rizzetto M, Mégraud F. Helicobacter species and liver diseases: association or causation? Lancet Infect Dis 2008;8:254-60.
7. Pellicano R, Franceschi F, Saracco G, Fagoonee S, Roccarina D, Gasbarrini A. Helicobacters and extragastric diseases. Helicobacter 2009;14(S1):58-68.
8. Berrutti M, Pellicano R, Astegiano M, Smedile A, Saracco G, Morgando A et al. Helicobacter pylori eradication: metronidazole or tinidazole? Data from Turin, Italy. Minerva Gastroenterol Dietol 2008;54:355-8.
9. Mendall MA, Patel P, Asante M, Ballam L, Morris J, Strachan DP et al. Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. Heart 1997;78:273-7. (Pubitemid 27431736)
10. Di Bonaventura G, Piccolomini R, Pompilio A, Zappacosta R, Piccolomini M, Neri M. Serum and mucosal cytokine profiles in patients with active Helicobacter pylori and ischemic heart disease: is there a relationship? Int J Immunopathol Pharmacol 2007;20:163-72. (Pubitemid 46506888)
11. Sjöbring U, Ringdahl U, Ruggeri ZM. Induction of platelet thrombi by bacteria and antibodies. Blood 2002;100:4470-7. (Pubitemid 35429687)
12. Byrne MF, Kerrigan SW, Corcoran PA, Atherton JC, Murray FE, Fitzgerald DJ et al. Helicobacter pylori binds von Willebrand factor and interacts with GPIb to induce platelet aggregation. Gastroenterology 2003;124:1846-54.
13. Gràbczewska Z, Nartowicz E, Kubica J, RoÊç D. Endothelial function parameters in patients with unstable angina and infection with Helicobacter pylori and Chlamydia pneumoniae. Eur J Int Med 2006;17:339-42. (Pubitemid 44096991)
14. Frishman WH. Biologic markers as predictors of cardiovascular disease. Am J Med 1998;104:18S-27S.
15. Consolazio A, Borgia MC, Ferro D, Iacopini F, Paoluzi OA, Crispino V et al. Increased thrombin generation and circulating levels of tumour necrosis factor-α in patients with chronic Helicobacter pylori-positive gastritis. Aliment Pharmacol Ther 2004;20:289-94. (Pubitemid 39062131)
16. Gensini GF, Conti AA.The preventive and therapeutic impart of antiplatelet agents: past and present. Minerva Med 2009;100:133-6.
17. Meade TW, Vickers MV, Thompson SG, Stirling Y, Haines AP, Miller GJ. Epidemiological characteristics of platelet aggregability. BMJ 1985;290:428-32.
18. Patel P, Mendall MA, Carrington D, Strachan DP, Leatham E, Molineaux N et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ 1995;311:711-4.
19. Zito F, Di Castelnuovo A, D'Orazio A, Negrini R, De Lucia D, Donati MB et al. Helicobacter pylori infection and the risk of myocardial infarction: role of fibrinogen and its genetic control. Thromb Haemost 1999;82:14-18. (Pubitemid 29368766)
20. Parente F, Imbesi V, Cucino C, MacOni G, Russo U, Duca PG et al. Helicobacter pylori CagA seropositivity does not influence inflammatory parameters, lipid concentrations and haemostatic factors in healthy individuals. J Intern Med 2000;247:213-7. (Pubitemid 30108355)
21. Torgano G, Cosentini R, Mandelli C, Perondi R, Blasi F, Bertinieri G et al. Treatment of Helicobacter pylori and Chlamydia pneumoniae infections decreases fibrinogen plasma level in patients with ischemic heart disease. Circulation 1999;99:1555-9. (Pubitemid 29152921)
22. Danesh J, Peto R. Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies. BMJ 1998;316:1130-2. (Pubitemid 28156459)
23. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 2000;321:199-204. (Pubitemid 30459555)
24. Elizalde JI, Pérez-Pujol S, Heras M, Sionis A, Casanovas N, Martorell T et al. Effect of Helicobacter pylori eradication on platelet activation and disease recurrence in patients with acute coronary syndromes. Helicobacter 2004;9:681-9. (Pubitemid 40023728)
25. Elizalde JI, Gomez J, Panes J, Lozano M, Casadevall M, Ramirez J et al. Platelet activation in mice and human Helicobacter pylori infection. J Clin Invest 1997;100:996-1005. (Pubitemid 27386283)
26. Jang Y, Lincoff AM, Plow EF, Topol EJ. Cell adhesion molecules in coronary artery disease. J Am Coll Cardiol 1994;24:1591-601. (Pubitemid 24369181)
27. Kalia N, Bardhan KD, Reed MW, Jacob S, Brown NJ. Effects of chronic administration of Helicobacter pylori extracts on rat gastric mucosal microcirculation in vivo. Dig Dis Sci 2000;45:1343-51. (Pubitemid 30636510)
28. Aguejouf O, Mayo K, Monteiro L, Doutremepuich F, Doutremepuich C, Mégraud F. Increase of arterial thrombosis parameters in chronic Helicobacter pylori infection in mice. Thrombosis Res 2003;108:245-8. (Pubitemid 36263143)
29. Rosenberg RD, Aird WC. Vascular-bed-specific hemostasis and hypercoagulable states. N Engl J Med 1999;340:1555-64.